Centene Reports $253 Million Loss Amid Health Insurer Cost Struggles

Company Overview - Centene reported a $253 million loss in the second quarter of 2025, equating to 51 cents per share, a significant decline from a net income of $1.1 billion, or $2.16 per share, in the same period last year [3][5] - The company experienced an 18% increase in premium and service revenues, rising to $42.5 billion from $36 billion year-over-year [3] Performance Challenges - Centene is facing rising costs among its health plan members across all three government-subsidized benefits it manages: Medicaid, Medicare Advantage, and individual coverage under the Affordable Care Act [4][9] - The health benefits ratio increased to 93% in Q2 2025, up from 87.6% in Q2 2024, indicating a higher percentage of premium revenue allocated to medical costs [7][8] Strategic Response - CEO Sarah London expressed disappointment in the second quarter results but emphasized a clear understanding of the trends affecting performance and a commitment to restoring earnings [5][6] - Centene plans to reveal its 2025 profit forecast, having previously pulled its financial guidance due to an independent analysis indicating that patients required more healthcare services than expected [6] Industry Context - Centene's cost struggles are part of a broader trend affecting health insurance companies, with several firms, including Elevance Health and Molina Healthcare, also lowering profit forecasts due to rising costs in government-subsidized plans [9][10] - UnitedHealth Group and CVS Health have similarly faced challenges, with UnitedHealth suspending its financial outlook and CVS exiting the individual health insurance market [11][12]